LIN28-LET7 MODULATES RADIOSENSITIVITY OF HUMAN CANCER CELLS WITH ACTIVATION OF K-RAS

被引:188
作者
Oh, Jee-Sun
Kim, Jae-Jin
Byun, Ju-Yeon
Kim, In-Ah [1 ,2 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Radiat Oncol, Med Sci Res Inst, Songnam 463707, Kyeonggido, South Korea
[2] Seoul Natl Univ, Canc Res Inst, Dept Radiat Oncol, Seoul, South Korea
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 76卷 / 01期
关键词
Lin28; let-7; microRNA; K-Ras; MICRORNAS; THERAPY; CARCINOMA; P53;
D O I
10.1016/j.ijrobp.2009.08.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the potential of targeting Lin28-let7 microRNA regulatory network for overcoming the radioresistance of cancer cells having activated K-Ras signaling. Methods and Materials: A549 lung carcinoma cells and ASPC1 pancreatic cancer cells possessing K-RAS mutation were transfected with pre-let7a microRNA or Lin28 siRNA, respectively. Clonogenic assay, quantitative reverse transcription polymerase chain reaction, and Western analysis were performed. The effects of Lin28 on SQ20B cells having wild-type K-RAS, and a normal fibroblast were also assessed. Results: The overexpression of let-7a decreased expression of K-Ras and radiosensitized A549 cells. Inhibition of Lin28, a repressor of let-7, attenuated K-Ras expression and radiosensitized A549 and ASPC1 cells. Neither SQ20B cells expressing wild-type K-RAS nor HDF, the normal human fibroblasts, were radiosensitized by this approach. Conclusions: The Lin28-let7 regulatory network may be a potentially useful therapeutic target for overcoming the radioresistance of human cancers having activated K-Ras signaling. (C) 2010 Elsevier Inc.
引用
收藏
页码:5 / 8
页数:4
相关论文
共 12 条
[1]   Trimodality treatment in stage III nonsmall cell lung carcinoma -: Prognostic impact of K-ras mutations after neoadjuvant therapy [J].
Broermann, P ;
Junker, K ;
Brandt, BH ;
Heinecke, A ;
Freitag, L ;
Klinke, F ;
Berdel, WE ;
Thomas, M .
CANCER, 2002, 94 (07) :2055-2062
[2]  
Dergham ST, 1997, INT J PANCREATOL, V21, P127
[3]   Targeting ras signalling pathways in cancer therapy [J].
Downward, J .
NATURE REVIEWS CANCER, 2003, 3 (01) :11-22
[4]   Oncomirs - microRNAs with a role in cancer [J].
Esquela-Kerscher, A ;
Slack, FJ .
NATURE REVIEWS CANCER, 2006, 6 (04) :259-269
[5]   Lin28 Mediates the Terminal Uridylation of let-7 Precursor MicroRNA [J].
Heo, Inha ;
Joo, Chirlmin ;
Cho, Jun ;
Ha, Minju ;
Han, Jinju ;
Kim, V. Narry .
MOLECULAR CELL, 2008, 32 (02) :276-284
[6]  
Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014
[7]   Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: Class differences and the potential influence of p53 [J].
Kim, IA ;
Shin, JH ;
Kim, IH ;
Kim, JH ;
Kim, JS ;
Wu, HG ;
Chie, EK ;
Ha, SW ;
Park, CI ;
Kao, GD .
CLINICAL CANCER RESEARCH, 2006, 12 (03) :940-949
[8]   Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines [J].
Kim, IA ;
Bae, SS ;
Fernandes, A ;
Wu, JM ;
Muschel, RJ ;
McKenna, WG ;
Birnbaum, MJ ;
Bernhard, EJ .
CANCER RESEARCH, 2005, 65 (17) :7902-7910
[9]   Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation [J].
Lai, EC .
NATURE GENETICS, 2002, 30 (04) :363-364
[10]  
MORRIS IVJ, 2005, SCI SKTE, P1